12-120988898-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM5_StrongPM2_SupportingPP3PM1
This summary comes from the ClinGen Evidence Repository: The c.392G>T variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of arginine to leucine at codon 131 (p.(R131L)) of NM_000545.8. This variant resides in an amino acid within the HNF1α DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1), and is predicted to be deleterious by computational evidence, with a REVEL score of 0.994, which is greater than the MDEP threshold of 0.70 (PP3). Two other missense variants, c.392G>A (p.Arg131Gln) and c.391C>T (p.Arg131Trp), have been interpreted as pathogenic by the ClinGen MDEP (PM5_Strong). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4 cannot be applied because this number is below the ClinGen MDEP threshold (ClinVar ID: 447488). Taken together, this evidence supports the classification of this variant as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 1.0, approved): PM5_Strong, PM1, PP3, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA386959454/MONDO:0015967/017
Frequency
Consequence
NM_000545.8 missense
Scores
Clinical Significance
Conservation
Publications
- monogenic diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- type 1 diabetes mellitus 20Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- maturity-onset diabetes of the young type 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- hyperinsulinism due to HNF1A deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- nonpapillary renal cell carcinomaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000545.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HNF1A | NM_000545.8 | MANE Select | c.392G>T | p.Arg131Leu | missense | Exon 2 of 10 | NP_000536.6 | ||
| HNF1A | NM_001306179.2 | c.392G>T | p.Arg131Leu | missense | Exon 2 of 10 | NP_001293108.2 | |||
| HNF1A | NM_001406915.1 | c.392G>T | p.Arg131Leu | missense | Exon 2 of 9 | NP_001393844.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HNF1A | ENST00000257555.11 | TSL:1 MANE Select | c.392G>T | p.Arg131Leu | missense | Exon 2 of 10 | ENSP00000257555.5 | ||
| HNF1A | ENST00000544413.2 | TSL:1 | c.392G>T | p.Arg131Leu | missense | Exon 2 of 10 | ENSP00000438804.1 | ||
| HNF1A | ENST00000538646.5 | TSL:1 | n.392G>T | non_coding_transcript_exon | Exon 2 of 6 | ENSP00000443964.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Monogenic diabetes Pathogenic:1
The c.392G>T variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of arginine to leucine at codon 131 (p.(Arg131Leu)) of NM_000545.8. This variant resides in an amino acid within the HNF1α DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1), and is predicted to be deleterious by computational evidence, with a REVEL score of 0.994, which is greater than the MDEP threshold of 0.70 (PP3). Two other missense variants, c.392G>A (p.Arg131Gln) and c.391C>T (p.Arg131Trp), have been interpreted as pathogenic by the ClinGen MDEP (PM5_Strong). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant was identified in an individual with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4 cannot be applied because this number is below the ClinGen MDEP threshold (ClinVar ID: 447488). Taken together, this evidence supports the classification of this variant as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 3.0.0, approved 6/30/2025): PM5_Strong, PM1, PP3, PM2_Supporting.
not provided Pathogenic:1
This variant has been identified in at least one individual with clinical features associated with this gene. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease. The variant is located in a region that is considered important for protein function and/or structure. Computational tools predict that this variant is damaging.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at